Skip to main content

Risk for Alzheimer Dementia Lower With Treated Versus Untreated HTN

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 15, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 14, 2024 -- Individuals with treated hypertension have a reduced risk for Alzheimer dementia (AD) compared with those with untreated hypertension, according to research published online Aug. 14 in Neurology.

Matthew J. Lennon, M.D., from the University of New South Wales in Sydney, and colleagues examined whether previous hypertension or antihypertensive use modifies AD or non-AD (all-cause dementia) risk in late life in an individual participant data meta-analysis that included community-based longitudinal studies of aging. The risks for developing AD and non-AD were examined as the main outcomes, while the main exposures were hypertension history/antihypertensive use and baseline systolic and diastolic blood pressure (BP). The analysis included 31,250 participants (mean baseline age, 72 years) from 14 nations.

The researchers found that compared with healthy controls and those with treated hypertension, participants with untreated hypertension had a significantly increased risk for AD (hazard ratios, 1.36 and 1.42, respectively). Both those with treated and untreated hypertension had greater non-AD risk compared with healthy controls (hazard ratios, 1.29 and 1.69, respectively), with no difference seen between the treated and untreated groups. In an analysis restricted to those with five-year follow-up, baseline BP had a significant U-shaped relationship with non-AD risk, but there were no other relationships seen between baseline BP and AD or non-AD risk.

"Throughout late life those with treated hypertension had a lower risk of AD compared with those with untreated hypertension, suggesting that antihypertensive use should be part of any AD prevention strategy even in late life," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2024

Read this next

Herpes Zoster Linked to Increased Long-Term Risk for Cognitive Decline

FRIDAY, Aug. 16, 2024 -- Herpes zoster (HZ) is associated with an increased long-term risk for subjective cognitive decline (SCD), according to a study published online Aug. 14 in...

FDA Starts Phase II of Efforts to Reduce Salt Levels in Food

THURSDAY, Aug. 15, 2024 -- The U.S. Food and Drug Administration on Thursday announced Phase II of its initial efforts to cut dietary salt intake by Americans. U.S. Dietary...

Mix of Factors Can ID Cognitive Decline in Early Alzheimer Disease

THURSDAY, Aug. 15, 2024 -- Even in early stages of Alzheimer disease (AD), cognitive deterioration is best predicted by a combination of patient demographic, somatic, and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.